Fun With Luciferase

Courtesy of RobmarCommon sense says that biotechnology is not child's play, but to former surgeon Bruce Bryan, it is. Bryan founded Pinetop, Ariz.-based Prolume to develop a line of glow-in-the-dark toys based on the luciferin/luciferase reaction, the same process behind firefly light and chemiluminescent assays.The idea dates back to Bryan's childhood, when he observed sea creatures lighting up the water during a scuba diving excursion. As an adult he tinkered with bioluminescence and eventuall

Written byAileen Constans
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Courtesy of Robmar

Common sense says that biotechnology is not child's play, but to former surgeon Bruce Bryan, it is. Bryan founded Pinetop, Ariz.-based Prolume to develop a line of glow-in-the-dark toys based on the luciferin/luciferase reaction, the same process behind firefly light and chemiluminescent assays.

The idea dates back to Bryan's childhood, when he observed sea creatures lighting up the water during a scuba diving excursion. As an adult he tinkered with bioluminescence and eventually added the marine luciferase protein into buffered beer to create a glowing beverage. "That was the first invention, making Bud Light light," Bryan says.

Gaining FDA approval for the concoction was another story, however, and Bryan eventually decided to put his effort into developing a squirt gun with a replaceable luciferin/luciferase cartridge. He licensed the idea to New Hampshire-based toy manufacturer Robmar, whose marketing manager, Diane Cote, expects a product to be released within ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies